Comperative Trial Between an Accommodative Iol and Monofocal Iol
Launched by SHAARE ZEDEK MEDICAL CENTER · Jan 29, 2008
Trial Information
Current as of June 24, 2025
Withdrawn
Keywords
ClinConnect Summary
A new accommodating IOL (Acuity Ltd, Israel) will be compared with Alcon's Acrysof for 1 year for visual acuity and distance and near best corrected visual acuity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 30 and 65
- • Required cataract operation in one or both eyes
- • BCVA potetial at least 20/30
- • Clear intraoccular media
- • Willing to participate in study as evidenced by signing a written Informed Consent
- • Exclusion Criteria:Main
- • Prior surgery at the selected eye
- • No light perception or poor potential for improvement
- • Phacodonesis and damaged zonules
- • Pupil size at least 6 mm.
- • History of uveitis
- • Macular disease decreasing vision below 20/30
- • Amblyopia
- • Axial length shorter than 21 mm and longer than 25 mm
About Shaare Zedek Medical Center
Shaare Zedek Medical Center, a leading healthcare institution located in Jerusalem, Israel, is dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its commitment to excellence in medical services, the center integrates cutting-edge technology with compassionate healthcare practices. With a multidisciplinary team of experienced researchers and clinicians, Shaare Zedek actively participates in various clinical trials aimed at exploring new treatments and therapies across multiple medical disciplines. The center prioritizes patient safety, ethical standards, and scientific rigor, ensuring that all research conducted aligns with the highest benchmarks of clinical excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials